(Q44552199)

4 December 2017

title

The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse (English)

1 reference

4 December 2017

Jeffrey W Chisholm

1

1 reference

4 December 2017

Jenny Hong

series ordinal

2

1 reference

4 December 2017

Scott A Mills

series ordinal

3

1 reference

4 December 2017

Richard M Lawn

series ordinal

4

1 reference

4 December 2017

publication date

16 August 2003

1 reference

Journal of Lipid Research

4 December 2017

published in

1 reference

4 December 2017

volume

44

1 reference

4 December 2017

issue

11

1 reference

4 December 2017

page(s)

2039-2048

1 reference

Role of LXRs in control of lipogenesis

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Nuclear receptors and lipid physiology: opening the X-files

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

PPARS, metabolic disease and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Autoregulation of the human liver X receptor alpha promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Phospholipid transfer protein is regulated by liver X receptors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Increased ABCA1 activity protects against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

The molecular genetics of rodent single gene obesities

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by triton WR-1339

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

On the role of liver X receptors in lipid accumulation in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300135-JLR200

10.1194/JLR.M300135-JLR200

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference